Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells

Frontiers in Microbiology

Volumn 6, Issue JUN, 2015, Pages

  Shin, Jae M ^a   Ateia, Islam ^a   Paulus, Jefrey R ^a   Liu, Hongrui ^a   Fenno, J Christopher ^a   Rickard, Alexander H ^b   Kapila, Yvonne L ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apoptosis; Confocal; Dental plaque; Human oral cells; Nisin; Oral diseases; Saliva derived multi species biofilms

Indexed keywords

NISIN;

APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BIOFILM; CELL ADHESION; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; EPIFLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MICROFLUIDIC ANALYSIS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; QUANTITATIVE ANALYSIS; SALIVA;

BACTERIA (MICROORGANISMS);

EID: 84936994910     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00617     Document Type: Article

References (91)

1. Aas, J. A., Paster, B. J., Stokes, L. N., Olsen, I., and Dewhirst, F. E. (2005). Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43, 5721-5732. doi: 10.1128/JCM.43.11.5721-5732.2005
2. Ahmed, N. A., Petersen, F. C., and Scheie, A. A. (2009). AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics. Antimicrob. Agents Chemother. 53, 4258-4263. doi: 10.1128/AAC.00546-09
3. Alifax, R., and Chevalier, R. (1962). Study of the nisinase produced by Streptococcus thermophilus. J. Dairy Res. 29, 233-240.
4. Allaker, R. P., and Douglas, C. I. (2009). Novel anti-microbial therapies for dental plaque-related diseases. Int. J. Antimicrob. Agents 33, 8-13. doi: 10.1016/j.ijantimicag.2008.07.014
5. Arthur, T. D., Cavera, V. L., and Chikindas, M. L. (2014). On bacteriocin delivery systems and potential applications. Future Microbiol. 9, 235-248. doi: 10.2217/fmb.13.148
6. Asaduzzaman, S. M., and Sonomoto, K. (2009). Lantibiotics: diverse activities and unique modes of action. J. Biosci. Bioeng. 107, 475-487. doi: 10.1016/j.jbiosc.2009.01.003
7. Baehni, P. C., Song, M., McCulloch, C. A., and Ellen, R. P. (1992). Treponema denticola induces actin rearrangement and detachment of human gingival fibroblasts. Infect. Immun. 60, 3360-3368.
8. Baehni, P. C., and Takeuchi, Y. (2003). Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis. 9(Suppl. 1), 23-29. doi: 10.1034/j.1601-0825.9.s1.5.x
9. Barrios, A. F. G., Zuo, R., Hashimoto, Y., Yang, L., Bentley, W. E., and Wood, T. K. (2006). Autoinducer 2 controls biofilm formation in Escherichia coli through a novel motility quorum-sensing regulator (MqsR, B3022). J. Bacteriol. 188, 305-316. doi: 10.1128/JB.188.1.305-316.2006
10. Begde, D., Bundale, S., Mashitha, P., Rudra, J., Nashikkar, N., and Upadhyay, A. (2011). Immunomodulatory efficacy of nisin-a bacterial lantibiotic peptide. J. Pept. Sci. 17, 438-444. doi: 10.1002/psc.1341
11. Bierbaum, G., and Sahl, H. G. (1985). Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch. Microbiol. 141, 249-254. doi: 10.1007/BF00408067
12. Bordi, C., and de Bentzmann, S. (2011). Hacking into bacterial biofilms: a new therapeutic challenge. Ann. Intensive Care 1, 1-8. doi: 10.1186/2110-5820-1-19
13. Breukink, E., Wiedemann, I., Van Kraaij, C., Kuipers, O. P., Sahl, H. G., and De Kruijff, B. (1999). Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361-2364. doi: 10.1126/science.286.5448.2361
14. Bush, K., and Macielag, M. (2000). New approaches in the treatment of bacterial infections. Curr. Opin. Chem. Biol. 4, 433-439. doi: 10.1016/S1367-5931(00)00106-X
15. Cao, L. T., Wu, J. Q., Xie, F., Hu, S. H., and Mo, Y. (2007). Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows. J. Dairy Sci. 90, 3980-3985. doi: 10.3168/jds.2007-0153
16. Carlson, S., and Bauer, H. (1957). A study of problems associated with resistance to nisin. Arch. Hyg. Bakteriol. 141, 445-460.
17. Chan, W. C., Dodd, H. M., Horn, N., Maclean, K., Lian, L. Y., Bycroft, B. W., et al. (1996). Structure-activity relationships in the peptide antibiotic nisin: role of dehydroalanine 5. Appl. Environ. Microbiol. 62, 2966-2969.
18. Chang, Y. C., Huang, F. M., Tai, K. W., and Chou, M. Y. (2001). The effect of sodium hypochlorite and chlorhexidine on cultured human periodontal ligament cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 92, 446-450. doi: 10.1067/moe.2001.116812
19. Choi, B. K., Lee, H. J., Kang, J. H., Jeong, G. J., Min, C. K., and Yoo, Y. J. (2003). Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. Infect. Immun. 71, 226-233. doi: 10.1128/IAI.71.1.226-233.2003
20. Chronic Disease Prevention and Health Promotion. (2015). Available at: http://www.cdc.gov/chronicdisease/resources/publications/aag/doh.htm [accessed: April 10, 2015].
21. Cleveland, J., Montville, T. J., Nes, I. F., and Chikindas, M. L. (2001). Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 71, 1-20. doi: 10.1016/S0168-1605(01)00560-8
22. Cline, N. V., and Layman, D. L. (1992). The effects of chlorhexidine on the attachment and growth of cultured human periodontal cells. J. Periodontol. 63, 598-602. doi: 10.1902/jop.1992.63.7.598
23. Corbin, A., Pitts, B., Parker, A., and Stewart, P. S. (2011). Antimicrobial penetration and efficacy in an in vitro oral biofilm model. Antimicrob. Agents Chemother. 55, 3338-3344. doi: 10.1128/AAC.00206-11
24. Cotter, P. D., Hill, C., and Ross, R. P. (2005). Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3, 777-788. doi: 10.1038/nrmicro1240
25. Cuadra-Saenz, G., Rao, D. L., Underwood, A. J., Belapure, S. A., Campagna, S. R., Sun, Z., et al. (2012). Autoinducer-2 influences interactions amongst pioneer colonizing streptococci in oral biofilms. Microbiology 158(Pt 7), 1783-1795. doi: 10.1099/mic.0.057182-0
26. Darveau, R. P. (2009). The oral microbial consortium's interaction with the periodontal innate defense system. DNA Cell Biol. 28, 389-395. doi: 10.1089/dna.2009.0864
27. de Freire Bastos, M., Coelho, M., and da Silva Santos, O. (2014). Resistance to bacteriocins produced by Gram-positive bacteria. Microbiology 161, 683-700. doi: 10.1128/MMBR.00051-14
28. De Kwaadsteniet, M., Doeschate, K. T., and Dicks, L. M. T. (2009). Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus. Lett. Appl. Microbiol. 48, 65-70. doi: 10.1111/j.1472-765X.2008.02488.x
29. Delves-Broughton, J., Blackburn, P., Evans, R. J., and Hugenholtz, J. (1996). Applications of the bacteriocin, nisin. Antonie van Leeuwenhoek 69, 193-202. doi: 10.1007/BF00399424
30. De Vuyst, L., and Vandamme, E. J. (1994). "Nisin, a lantibiotic produced by Lactococcus lactis subsp. lactis: properties, biosynthesis, fermentation and applications," in Bacteriocins of Lactic Acid Bacteria, eds L. De Vuyst and E. J. Vandamme (New York, NY: Springer), 151-221.
31. Draper, L. A., Cotter, P. D., Hill, C., and Ross, R. P. (2015). Lantibiotic resistance. Microbiol. Mol. Biol. Rev. 79, 171-191. doi: 10.1099/mic.0.082289-0
32. Eckert, R., He, J., Yarbrough, D. K., Qi, F., Anderson, M. H., and Shi, W. (2006). Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrobial. Agents Chemother. 50, 3651-3657. doi: 10.1128/AAC.00622-06
33. FDA Federal Register. (1998). Nisin preparation: affirmation of GRAS status as a direct human food ingredient. 21 CFR Part 184. Fed. Reg. 53, 11247-11251.
34. Fenno, J. C. (2005). Laboratory maintenance of Treponema denticola. Curr. Protoc. Microbiol. Chap. 12, 12B.1. doi: 10.1002/9780471729259.mc12b01s00
35. Fernández, L., Delgado, S., Herrero, H., Maldonado, A., and Rodríguez, J. M. (2008). The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation. J. Hum. Lact. 24, 311-316. doi: 10.1177/0890334408317435
36. Flötra, L., Gjermo, P., Rölla, G., and Waerhaug, J. (1971). Side effects of chlorhexidine mouth washes. Eur. J. Oral Sci. 79, 119-125. doi: 10.1111/j.1600-0722.1971.tb02001.x
37. Gagari, E., and Kabani, S. (1995). Adverse effects of mouthwash use: a review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 80, 432-439. doi: 10.1016/S1079-2104(05)80337-3
38. Gilbert, P., Maira-Litran, T., McBain, A. J., Rickard, A. H., and Whyte, F. W. (2002). The physiology and collective recalcitrance of microbial biofilm communities. Adv. Microbial. Physiol. 46, 203-256. doi: 10.1016/S0065-2911(02)46005-5
39. Goldschmidt, P., Cogen, R., and Taubman, S. (1977). Cytopathologic effects of chlorhexidine on human cells. J. Periodontol. 48, 212-215. doi: 10.1902/jop.1977.48.4.212
40. Gopalsami, C., Yotis, W., Corrigan, K., Schade, S., Keene, J., and Simonson, L. (1993). Effect of outer membrane of Treponema denticola on bone resorption. Oral Microbiol. Immunol. 8, 121-124. doi: 10.1111/j.1399-302X.1993.tb00557.x
41. Gross, E., and Morell, J. L. (1971). Structure of nisin. J. Am. Chem. Soc. 93, 4634-4635. doi: 10.1021/ja00747a073
42. Haffajee, A. D., and Socransky, S. S. (1994). Microbial etiological agents of destructive periodontal diseases. Periodontology 2000 5, 78-111. doi: 10.1111/j.1600-0757.1994.tb00020.x
43. Hancock, R. E., and Diamond, G. (2000). The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8, 402-410. doi: 10.1016/S0966-842X(00)01823-0
44. Hans, M., and Madaan Hans, V. (2014). Epithelial antimicrobial peptides: guardian of the oral cavity. Int. J. Pept. 2014, 13. doi: 10.1155/2014/370297
45. Hojo, K., Nagaoka, S., Ohshima, T., and Maeda, N. (2009). Bacterial interactions in dental biofilm development. J. Dent. Res. 88, 982-990. doi: 10.1177/0022034509346811
46. Howell, T. H., Fiorellini, J. P., Blackburn, P., Projan, S. J., Harpe, J., and Williams, R. C. (1993). The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs. J. Clin. Periodontol. 20, 335-339. doi: 10.1111/j.1600-051X.1993.tb00369.x
47. Izano, E. A., Wang, H., Ragunath, C., Ramasubbu, N., and Kaplan, J. B. (2007). Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J. Dent. Res. 86, 618-622. doi: 10.1177/154405910708600707
48. Jakubovics, N. S., and Kolenbrander, P. E. (2010). The road to ruin: the formation of disease-associated oral biofilms. Oral Dis. 16, 729-739. doi: 10.1111/j.1601-0825.2010.01701.x
49. Jones, C. G. (1997). Chlorhexidine: is it still the gold standard? Periodontology 2000 15, 55-62. doi: 10.1111/j.1600-0757.1997.tb00105.x
50. Joo, N. E., Ritchie, K., Kamarajan, P., Miao, D., and Kapila, Y. L. (2012). Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 1, 295-305. doi: 10.1002/cam4.35
51. Kaplan, J.á. (2010). Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses. J. Dent. Res. 89, 205-218. doi: 10.1177/0022034509359403
52. Kasibhatla, S., Amarante-Mendes, G. P., Finucane, D., Brunner, T., Bossy-Wetzel, E., and Green, D. R. (2006). Acridine orange/ethidium bromide (AO/EB) staining to detect apoptosis. Cold Spring Harb. Protoc. 2006:4493. doi: 10.1101/pdb.prot4493
53. Katharios-Lanwermeyer, S., Xi, C., Jakubovics, N. S., and Rickard, A. H. (2014). Mini-review: microbial coaggregation: ubiquity and implications for biofilm development. Biofouling 30, 1235-1251. doi: 10.1080/08927014.2014.976206
54. Kindrachuk, J., Jenssen, H., Elliott, M., Nijnik, A., Magrangeas-Janot, L., Pasupuleti, M., et al. (2013). Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory. Innate Immun. 19, 315-327. doi: 10.1177/1753425912461456
55. Kolderman, E., Bettampadi, D., Samarian, D., Dowd, S., Foxman, B., Jakubovics, N., et al. (2015). L-arginine destabilizes oral multi-species biofilm communities developed in human saliva. PLoS ONE 10:e0121835. doi: 10.1371/journal.pone.0121835
56. Kolenbrander, P. E., Palmer, R. J., Periasamy, S., and Jakubovics, N. S. (2010). Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 8, 471-480. doi: 10.1038/nrmicro2381
57. Kooy, J. S. (1952). Strains of Lactobacillus plantarum which inhibit the activity of the antibiotics produced by Streptococcus lactis. Ned. Melk Zuiveltijdschr. 6, 323-330.
58. Marsh, P. D. (2003). Are dental diseases examples of ecological catastrophes? Microbiology 149, 279-294. doi: 10.1128/JCM.43.11.5721-5732.2005
59. Marsh, P. D. (2010). Controlling the oral biofilm with antimicrobials. J. Dent. 38, S11-S15. doi: 10.1016/S0300-5712(10)70005-1
60. Mulders, J. W., Boerrigter, I. J., Rollema, H. S., Siezen, R. J., and Vos, W. M. (1991). Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur. J. Biochem. 201, 581-584. doi: 10.1111/j.1432-1033.1991.tb16317.x
61. Nance, W. C., Dowd, S. E., Samarian, D., Chludzinski, J., Delli, J., Battista, J., et al. (2013). A high-throughput microfluidic dental plaque biofilm system to visualize and quantify the effect of antimicrobials. J. Antimicrob. Chemother. 68, 2550-2560. doi: 10.1093/jac/dkt211
62. Ohta, K., Mäkinen, K. K., and Loesche, W. J. (1986). Purification and characterization of an enzyme produced by Treponema denticola capable of hydrolyzing synthetic trypsin substrates. Infect. Immun. 53, 213-220.
63. Pablo, M. A., Gaforio, J. J., Gallego, A. M., Ortega, E., Gálvez, A. M., and Alvarez de Cienfuegos López, G. (1999). Evaluation of immunomodulatory effects of nisin-containing diets on mice. FEMS Immun. Med. Microbiol. 24, 35-42. doi: 10.1111/j.1574-695X.1999.tb01262.x
64. Pag, U., and Sahl, H. G. (2002). Multiple activities in lantibiotics-models for the design of novel antibiotics? Curr. Pharm. Des. 8, 815-833. doi: 10.2174/1381612023395439
65. Pankey, G. A., and Sabath, L. D. (2004). Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin. Infect. Dis. 38, 864-870. doi: 10.1086/381972
66. Pepperney, A., and Chikindas, M. L. (2011). Antibacterial peptides: opportunities for the prevention and treatment of dental caries. Probiotics Antimicrob. Proteins 3, 68-96. doi: 10.1007/s12602-011-9076-5
67. Peschel, A., and Sahl, H. G. (2006). The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4, 529-536. doi: 10.1038/nrmicro1441
68. Pihlstrom, B. L., Michalowicz, B. S., and Johnson, N. W. (2005). Periodontal diseases. Lancet 366, 1809-1820. doi: 10.1016/S0140-6736(05)67728-8
69. Raffa, R. B., Iannuzzo, J. R., Levine, D. R., Saeid, K. K., Schwartz, R. C., Sucic, N. T., et al. (2005). Bacterial communication ("quorum sensing") via ligands and receptors: a novel pharmacologic target for the design of antibiotic drugs. J. Pharmacol. Exp. Ther. 312, 417-423. doi: 10.1124/jpet.104.075150
70. Rayman, K., Malik, N., and Hurst, A. (1983). Failure of nisin to inhibit out- growth of Clostridium botulinum in a model cured meat system. Appl. Environ. Microbiol. 46, 1450-1452.
71. Ribble, D., Goldstein, N. B., Norris, D. A., and Shellman, Y. G. (2005). A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 5:12. doi: 10.1186/1472-6750-5-12
72. Rickard, A. H., Palmer, R. J., Blehert, D. S., Campagna, S. R., Semmelhack, M. F., Egland, P. G., et al. (2006). Autoinducer 2: a concentration-dependent signal for mutualistic bacterial biofilmgrowth. Mol. Microbiol. 60, 1446-1456. doi: 10.1111/j.1365-2958.2006.05202.x
73. Riviere, G. R., Elliot, K. S., Adams, D. F., Simonson, L. G., Forgas, L. B., Nilius, A. M., et al. (1992). Relative proportions of pathogen-related oral spirochetes (PROS) and Treponema denticola in supragingival and subgingival plaque from patients with periodontitis. J. Periodontol. 63, 131-136. doi: 10.1902/jop.1992.63.2.131
74. Sahl, H. G., and Bierbaum, G. (1998). Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu. Rev. Microbiol. 52, 41-79. doi: 10.1146/annurev.micro.52.1.41
75. Samarian, D. S., Jakubovics, N. S., Luo, T. L., and Rickard, A. H. (2014). Use of a high-throughput in vitro microfluidic system to develop oral multi-species biofilms. J. Vis. Exp. 94:e52467. doi: 10.3791/52467
76. Scanlon, C. S., Marchesan, J. T., Soehren, S., Matsuo, M., and Kapila, Y. L. (2011). Capturing the regenerative potential of periodontal ligament fibroblasts. J. Stem Cells Regen. Med. 7, 54-56.
77. Severina, E., Severin, A., and Tomasz, A. (1998). Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens. J. Antimicrob. Chemother. 41, 341-347. doi: 10.1093/jac/41.3.341
78. Smith, L., and Hillman, J. D. (2008). Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics. Curr. Opin. Microbiol. 11, 401-408. doi: 10.1016/j.mib.2008.09.008
79. Smith, R. N., Andersen, R. N., and Kolenbrander, P. E. (1991). Inhibition of intergeneric coaggregation among oral bacteria by cetylpyridinium chloride, chlorhexidine digluconate and octenidine dihydrochloride. J. Periodontal Res. 26, 422-428. doi: 10.1111/j.1600-0765.1991.tb01732.x
80. Todorov, S. D., Botes, M., Danova, S. T., and Dicks, L. M. T. (2007). Probiotic properties of Lactococcus lactis ssp. lactis HV219, isolated from human vaginal secretions. J. Appl. Microbiol. 103, 629-639. doi: 10.1111/j.1365-2672.2007.03290.x
81. Tong, Z., Dong, L., Zhou, L., Tao, R., and Ni, L. (2010). Nisin inhibits dental caries-associated microorganism in vitro. Peptides 31, 2003-2008. doi: 10.1016/j.peptides.2010.07.016
82. U.S. Food and Drug Administration. (1988). Nisin preparation: affirmation of GRAS status as direct human food ingredient. Fed. Reg. 53, 11247-11251.
83. Valenta, C., Bernkop-Schnürch, A., and Rigler, H. P. (1996). The antistaphylococcal effect of nisin in a suitable vehicle: a potential therapy for atopic dermatitis in man. J. Pharm. Pharmacol. 48, 988-991. doi: 10.1111/j.2042-7158.1996.tb06019.x
84. Vinderola, C. G., and Reinheimer, J. A. (2003). Lactic acid starter and probiotic bacteria: a comparative "in vitro" study of probiotic characteristics and biological barrier resistance. Food Res. Int. 36, 895-904. doi: 10.1016/S0963-9969(03)00098-X
85. Weinberg, A., Krisanaprakornkit, S., and Dale, B. A. (1998). Epithelial antimicrobial peptides: review and significance for oral applications. Crit. Rev. Oral Biol. Med. 9, 399-414. doi: 10.1177/10454411980090040201
86. Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., et al. (2001). Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276, 1772-1779. doi: 10.1074/jbc.M006770200
87. Wiegand, I., Hilpert, K., and Hancock, R. E. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3, 163-175. doi: 10.1038/nprot.2007.521
88. Wikler, M. A. (2006). Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement, Vol. 26. Wayne, PA: Clinical and Laboratory Standards Institute.
89. Willey, J. M., and van der Donk, W. A. (2007). Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61, 477-501. doi: 10.1146/annurev.micro.61.080706.093501
90. Wu, J., Hu, S., and Cao, L. (2007). Therapeutic effect of nisin Z on subclinical mastitis in lactating cows. Antimicrob. Agents Chemother. 51, 3131-3135. doi: 10.1128/AAC.00629-07
91. Zijnge, V., van Leeuwen, M. B. M., Degener, J. E., Abbas, F., Thurnheer, T., Gmür, R., et al. (2010). Oral biofilm architecture on natural teeth. PLoS ONE 5:e9321. doi: 10.1371/journal.pone.0009321